6L6-17348-92845
3 vaccinations
3 coded responses
38 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 306 / GA
- Registered
- 2021-03-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-24
Dose 1 — Pfizer-BioNTech
-
2021-03-25
Registered in v-safe
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-04-01
-
2021-04-07
Survey response — day 14, dose 1MedDRA: Injection site bruising, Injection site erythema, Injection site pain, Injection site pruritus, Injection site rash, Injection site swelling, Injection site warmth, Rash erythematous, Rash papular, Rash pruritic — Feeling: GoodFree text: Eight days after vaccine 1, the injection site on my left arm developed a raised red rash that was warm to the touch and 1-2 inches in diameter. It lasted for 2-3 days, was slightly itchy, and painful when pressure applied. A light bruise remains.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-14
Dose 2 — Pfizer-BioNTech
- 2021-04-14
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-17
- 2021-04-18
- 2021-04-19
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-12
- 2021-05-19
- 2021-05-26
- 2021-07-17
-
2021-10-13
Survey response — 6 months, dose 2MedDRA: Impaired work ability, Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend schoolFree text: I contacted a cold of some kind and missed work for a few days. My COVID-19 PCR test taken during this time came back negative.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-12
Dose 3 — Pfizer-BioNTech
- 2021-12-12
-
2021-12-13
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-14
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · NauseaAdult check-in
- 2021-12-15
- 2021-12-16
-
2021-12-17
Survey response — days 1–6 daily, dose 3MedDRA: Nasal congestion — Feeling: GoodFree text: Some mild nasal congestion, probably unrelatedMedDRA releases: 2024-11 · check-in free text available
- 2021-12-18
- 2021-12-19
- 2021-12-26
- 2022-01-02
- 2022-01-09
- 2022-01-16
- 2022-01-23
- 2022-03-13
- 2022-06-12
- 2022-12-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Pfizer-BioNTech | |
| 2 | 2021-04-14 | Pfizer-BioNTech | |
| 3 | 2021-12-12 | Pfizer-BioNTech | No |
Free text
Release 7 — day 14, dose 1
Symptoms: Eight days after vaccine 1, the injection site on my left arm developed a raised red rash that was warm to the touch and 1-2 inches in diameter. It lasted for 2-3 days, was slightly itchy, and painful when pressure applied. A light bruise remains.
Release 10 — 6 months, dose 2
Symptoms: I contacted a cold of some kind and missed work for a few days. My COVID-19 PCR test taken during this time came back negative.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Some mild nasal congestion, probably unrelated
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Impaired work ability | · | · | ✓ |
| SD | Injection site bruising | ✓ | ✓ | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Injection site warmth | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rash erythematous | ✓ | ✓ | ✓ |
| SD | Rash papular | ✓ | ✓ | ✓ |
| SD | Rash pruritic | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release